CON Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, NEC · NYSE · SEC CIK 2014596 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.8%
TTM net income YoY41.2%
TTM EPS YoY44.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin29.9%
Operating margin16.9%
Net margin9.3%
FCF margin11.0%
EBITDA margin20.3%
Returns
ROE48.5%
ROA7.4%
ROIC (approx.)15.6%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets82.2%
Debt / equity3.00x
Current ratio1.30x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.51x
Accruals ratio-3.8%
Payout ratio14.8%
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.16B | $1.90B |
| Cost of revenue | $1.55B | $1.37B |
| Gross profit | $613.09M | $527.98M |
| SG&A expense | $203.31M | $156.32M |
| Operating income | $333.99M | $304.76M |
| Interest expense | $109.29M | $47.71M |
| Pretax income | $223.83M | $231.39M |
| Income tax | $50.98M | $59.50M |
| Net income | $166.41M | $166.54M |
| EBITDA | $409.81M | $371.94M |
| EPS (basic) | 1.30 | 1.46 |
| EPS (diluted) | 1.30 | 1.46 |
| Dividends declared per share | 0.25 | 0.06 |
| Weighted avg. shares (diluted) | 128.30M | 114.20M |
| Balance sheet | ||
| Cash & equivalents | $79.90M | $183.25M |
| Receivables | $257.90M | $217.72M |
| Current assets | $383.10M | $437.21M |
| PP&E, net | $225.31M | $197.93M |
| Goodwill | $1.48B | $1.23B |
| Intangibles | $242.56M | $204.72M |
| Total assets | $2.86B | $2.52B |
| Current liabilities | $337.25M | $307.19M |
| Short-term debt | $10.74M | $10.09M |
| Long-term debt | $1.56B | $1.47B |
| Total debt | $1.57B | $1.48B |
| Total liabilities | $2.44B | $2.22B |
| Shareholders' equity | $393.28M | $275.67M |
| Net debt | $1.49B | $1.30B |
| Shares outstanding | 128.63M | 128.13M |
| Cash flow statement | ||
| Operating cash flow | $279.40M | $274.68M |
| Capital expenditure | $82.33M | $64.33M |
| Free cash flow | $197.06M | $210.35M |
| Investing cash flow | -$414.86M | -$71.27M |
| Financing cash flow | $32.10M | -$51.53M |
| Depreciation & amortization | $75.82M | $67.18M |
| Stock-based compensation | $10.49M | $2.33M |
| Dividends paid | $32.08M | $7.96M |
| Share buybacks | $22.42M | $15.40M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.